vimarsana.com

Page 5 - Gerhard Dahlhoff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia

/PRNewswire/ OncoBeta® GmbH, a medical device company specialized in innovative epidermal radioisotope therapies announced today that the company has.

New yorkUnited statesNorth sydneyNew south walesUnited kingdomSaima vohraGerhard dahlhoffShannond brownOncobeta gmbTherapeutic nuclear medicineNational healthClinical research organizationResearch councilTherapeutic goods administrationMedical research councilComplete response rate

OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia

/PRNewswire/ OncoBeta® GmbH, a medical device company specialized in innovative epidermal radioisotope therapies announced today that the company has.

New yorkUnited statesNorth sydneyNew south walesUnited kingdomSaima vohraGerhard dahlhoffShannond brownOncobeta gmbTherapeutic nuclear medicineNational healthClinical research organizationResearch councilTherapeutic goods administrationMedical research councilComplete response rate

OncoBeta launches International Registry for Non-Melanoma Skin Cancer

/PRNewswire/ OncoBeta® GmbH announces the launch of a first-of-its-kind International Registry for NMSC. The launch is a momentous achievement for OncoBeta,.

New yorkUnited statesSaima vohraGerhard dahlhoffPaolo castellucciShannond brownOncobeta webeOncobeta gmbTherapeutic nuclear medicineInternational registryMedical directorOncobeta australiaSkin cancer therapyBasal cell carcinomasSquamous cell carcinomasAvidata clinical cloud

OncoBeta launches International Registry for Non-Melanoma Skin Cancer

/PRNewswire/ OncoBeta® GmbH announces the launch of a first-of-its-kind International Registry for NMSC. The launch is a momentous achievement for OncoBeta,.

New yorkUnited statesSaima vohraGerhard dahlhoffPaolo castellucciShannond brownOncobeta webeOncobeta gmbTherapeutic nuclear medicineInternational registryMedical directorOncobeta australiaSkin cancer therapyBasal cell carcinomasSquamous cell carcinomasAvidata clinical cloud

OncoBeta initiates international EPIC-Skin study with Rhenium-SCT® for the treatment of Skin Cancer

OncoBeta initiates international EPIC-Skin study with Rhenium-SCT® for the treatment of Skin Cancer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomGerhard dahlhoffShannond brownOncobeta gmbTherapeutic nuclear medicineContract research organizationComplete response ratePersonalised irradiationPatient reported outcome measuresMedical directorSkin studyManaging directorSkin cancer therapyBasal cell carcinomas

vimarsana © 2020. All Rights Reserved.